About Citizenplus Pharmaceuticals
Citizenplus Pharmaceuticals is a company based in Hyderabad (India) founded in 2015. It operates as a B2B. The company has 26 employees as of March 31, 2022. Citizenplus Pharmaceuticals offers products and services including Omeprazole Pellets, Lansoprazole Pellets, Domperidone SR Pellets, and Tamsulosin HCL SR Pellets. Citizenplus Pharmaceuticals operates in a competitive market with competitors including Suanfarma, Enzene Biosciences, Hybio Pharmaceutical, Nephron Pharmaceuticals and Kardigan, among others.
- Headquarter Hyderabad, India
- Employees 26 as on 31 Mar, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Citizenplus Pharmaceuticals Private Limited
- Date of Incorporation 22 Apr, 2015
- Jurisdiction Jubilee Hills, Telangana, India
-
Annual Revenue
$1.84 M (USD)116.16as on Mar 31, 2022
-
Net Profit
$23.12 K (USD)-21.92as on Mar 31, 2022
-
EBITDA
$135.78 K (USD)204.15as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
26
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Citizenplus Pharmaceuticals
Citizenplus Pharmaceuticals offers a comprehensive portfolio of products and services, including Omeprazole Pellets, Lansoprazole Pellets, Domperidone SR Pellets, and Tamsulosin HCL SR Pellets.
Pellets for treating acid-related disorders in pharmaceuticals.
Used for gastric acid suppression in medical applications.
Sustained release for nausea and vomiting treatment.
Pellets for prostate health management.
Funding Insights of Citizenplus Pharmaceuticals
Detailed funding history for Citizenplus Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Citizenplus Pharmaceuticals
Investment portfolio details for Citizenplus Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Citizenplus Pharmaceuticals
Detailed financials for Citizenplus Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Citizenplus Pharmaceuticals Comparisons
Peer comparison for Citizenplus Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Citizenplus Pharmaceuticals
Citizenplus Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Suanfarma, Enzene Biosciences, Hybio Pharmaceutical, Nephron Pharmaceuticals and Kardigan, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Generics, nutraceuticals, and APIs are developed by Suanfarma.
|
|
| Locked | Locked | Locked |
Company specializing in development of Biosimilars
|
|
| Locked | Locked | Locked |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| Locked | Locked | Locked |
Sterile pharmaceutical products are manufactured and contract services are provided.
|
|
| Locked | Locked | Locked |
Biotech company developing personalized medicines for cardiovascular diseases
|
|
| Locked | Locked | Locked |
APIs and finished dosage forms are developed and manufactured.
|
Detailed competitors of Citizenplus Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Citizenplus Pharmaceuticals
Complete news archive for Citizenplus Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Citizenplus Pharmaceuticals
Citizenplus Pharmaceuticals was founded in 2015.
Citizenplus Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Mar 31, 2022, the latest employee count at Citizenplus Pharmaceuticals is 26.
Annual revenue of Citizenplus Pharmaceuticals is $1.84M as on Mar 31, 2022.
Citizenplus Pharmaceutical is a growing company based in Hyderabad, India, specializing in the production of pharmaceutical pellets and granules. Established in 2015, it focuses on developing and marketing well-researched products for the healthcare sector. The company operates manufacturing facilities in Telangana, serving global markets through B2B channels. It emphasizes quality and innovation in its processes, targeting pharmaceutical intermediates and related products.
Citizenplus Pharmaceuticals's top competitors include Nephron Pharmaceuticals, Suanfarma and Enzene Biosciences.
Citizenplus Pharmaceuticals offers Omeprazole Pellets, Lansoprazole Pellets, Domperidone SR Pellets, and Tamsulosin HCL SR Pellets.